UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nonalcoholic fatty liver disease in India – a lot done, yet more required

Indian journal of gastroenterology, 2010-11, Vol.29 (6), p.217-225

Duseja, Ajay

2010

Volltextzugriff (PDF)

Letter: long‐term abdominal drains in refractory ascites—evolving concept of palliative care in decompensated cirrhosis

Alimentary pharmacology & therapeutics, 2020-10, Vol.52 (7), p.1266-1267

2020

Volltextzugriff (PDF)

Endoscopic Ultrasound-Guided Transgastric Shunt Obliteration for Recurrent Hepatic Encephalopathy

The American journal of gastroenterology, 2023-10, Vol.118 (10), p.1895-1898

2023

Volltextzugriff (PDF)

Flare of Autoimmune Hepatitis Causing Acute on Chronic Liver Failure: Diagnosis and Response to Corticosteroid Therapy

Hepatology (Baltimore, Md.), 2019-08, Vol.70 (2), p.587-596

2019

Volltextzugriff (PDF)

Sofosbuvir and Velpatasvir combination is safe and effective in treating chronic hepatitis C in end‐stage renal disease on maintenance haemodialysis

Liver international, 2021-04, Vol.41 (4), p.705-709

2021

Volltextzugriff (PDF)

Clinical and patient‐reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry

Journal of viral hepatitis, 2023-04, Vol.30 (4), p.335-344

2023

Volltextzugriff (PDF)

Health-related quality of life among liver disorder patients in Northern India

Indian journal of community medicine, 2022-01, Vol.47 (1), p.76-81

2022

Volltextzugriff (PDF)

Idiopathic Hypercalcemia in Decompensated Cirrhosis: Reexploring an Entity in Oblivion

Journal of clinical and experimental hepatology, 2021-03, Vol.11 (2), p.270-272

2021

Volltextzugriff (PDF)

Non-alcoholic Fatty Liver Disease: East Versus West

Journal of clinical and experimental hepatology, 2012-06, Vol.2 (2), p.122-134

2012

Volltextzugriff (PDF)

Burden, risk factors, and outcomes of multidrug-resistant bacterial colonisation at multiple sites in patients with cirrhosis

JHEP reports, 2023-08, Vol.5 (8), p.100788-100788, Article 100788

2023

Volltextzugriff (PDF)

Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD)

Translational gastroenterology and hepatology, 2021-01, Vol.6, p.2-2

2021

Volltextzugriff (PDF)

Letter to the editor: Spontaneous regression of cirrhosis: A paradigm shift in our understanding of the natural history of NASH

Hepatology (Baltimore, Md.), 2022-07, Vol.76 (1), p.E1-E2

2022

Volltextzugriff (PDF)

Neutrophil dysfunction predicts 90‐day survival in patients with acute on chronic liver failure: A longitudinal case–control study

JGH open, 2020-08, Vol.4 (4), p.595-602

2020

Volltextzugriff (PDF)

Letter to the editor: Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study—Should we extend the boundaries?

Hepatology (Baltimore, Md.), 2022-10, Vol.76 (4), p.E80-E81

2022

Volltextzugriff (PDF)

Spontaneous Bacterial Peritonitis by Burkholderia cepacia Complex: A Rare, Difficult to Treat Infection in Decompensated Cirrhotic Patients

Journal of clinical and experimental hepatology, 2017-06, Vol.7 (2), p.102-106

2017

Volltextzugriff (PDF)

Screening of Cardiovascular Disease in Nonalcoholic Fatty Liver Disease: Whom and How?

Journal of clinical and experimental hepatology, 2019-07, Vol.9 (4), p.506-514

2019

Volltextzugriff (PDF)

Decentralized care with generic direct-acting antivirals in the management of chronic hepatitis C in a public health care setting

Journal of hepatology, 2019-12, Vol.71 (6), p.1076-1085

2019

Volltextzugriff (PDF)

Assessment of Sarcopenia Using Muscle Ultrasound in Patients With Cirrhosis and Sarcopenic Obesity (AMUSE STUDY)

Journal of clinical gastroenterology, 2023-09, Vol.57 (8), p.841-847

2023

Volltextzugriff (PDF)

Therapeutic plasma exchange is a safe and effective bridge therapy in patients with alcohol‐associated ACLF not having immediate prospects for liver transplantation—A case‐control, pilot study

Journal of clinical apheresis, 2022-12, Vol.37 (6), p.553-562

2022

Volltextzugriff (PDF)

Myokines are associated with progression, course and mortality in alcohol‐associated liver disease

Alimentary pharmacology & therapeutics, 2024-10, Vol.60 (8), p.1005-1020

2024

Volltextzugriff (PDF)

Sofosbuvir plus velpatasvir combination for the treatment of chronic hepatitis C in patients with end stage renal disease on renal replacement therapy: A systematic review and meta‐analysis

Nephrology (Carlton, Vic.), 2022-01, Vol.27 (1), p.82-89

2022

Volltextzugriff (PDF)

Home‐based intensive nutrition therapy improves frailty and sarcopenia in patients with decompensated cirrhosis: A randomized clinical trial

Journal of gastroenterology and hepatology, 2023-02, Vol.38 (2), p.210-218

2023

Volltextzugriff (PDF)

Efficacy and safety of pan‐genotypic sofosbuvir and velpatasvir in patients with hepatitis C and HIV coinfection on dolutegravir‐based antiretroviral therapy

Journal of viral hepatitis, 2023-09, Vol.30 (9), p.740-745

2023

Volltextzugriff (PDF)

Combined PEG3350 Plus Lactulose Results in Early Resolution of Hepatic Encephalopathy and Improved 28-Day Survival in Acute-on-Chronic Liver Failure

Journal of clinical gastroenterology, 2022-01, Vol.56 (1), p.e11-e19

2022

Volltextzugriff (PDF)

Toward a Better Definition of Acute-on-Chronic Liver Failure

Journal of clinical and experimental hepatology, 2017-09, Vol.7 (3), p.262-265

2017

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

ThemaMiddle Aged

ThemaCirrhosis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(47)

Sprache

Englisch
(47)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nonalcoholic fatty liver disease in India – a lot done, yet more required

Letter: long‐term abdominal drains in refractory ascites—evolving concept of palliative care in decompensated cirrhosis

Endoscopic Ultrasound-Guided Transgastric Shunt Obliteration for Recurrent Hepatic Encephalopathy

Flare of Autoimmune Hepatitis Causing Acute on Chronic Liver Failure: Diagnosis and Response to Corticosteroid Therapy

Sofosbuvir and Velpatasvir combination is safe and effective in treating chronic hepatitis C in end‐stage renal disease on maintenance haemodialysis

Clinical and patient‐reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry

Health-related quality of life among liver disorder patients in Northern India

Idiopathic Hypercalcemia in Decompensated Cirrhosis: Reexploring an Entity in Oblivion

Non-alcoholic Fatty Liver Disease: East Versus West

Burden, risk factors, and outcomes of multidrug-resistant bacterial colonisation at multiple sites in patients with cirrhosis

Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD)

Letter to the editor: Spontaneous regression of cirrhosis: A paradigm shift in our understanding of the natural history of NASH

Neutrophil dysfunction predicts 90‐day survival in patients with acute on chronic liver failure: A longitudinal case–control study

Letter to the editor: Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study—Should we extend the boundaries?

Spontaneous Bacterial Peritonitis by Burkholderia cepacia Complex: A Rare, Difficult to Treat Infection in Decompensated Cirrhotic Patients

Screening of Cardiovascular Disease in Nonalcoholic Fatty Liver Disease: Whom and How?

Decentralized care with generic direct-acting antivirals in the management of chronic hepatitis C in a public health care setting

Assessment of Sarcopenia Using Muscle Ultrasound in Patients With Cirrhosis and Sarcopenic Obesity (AMUSE STUDY)

Therapeutic plasma exchange is a safe and effective bridge therapy in patients with alcohol‐associated ACLF not having immediate prospects for liver transplantation—A case‐control, pilot study

Myokines are associated with progression, course and mortality in alcohol‐associated liver disease

Sofosbuvir plus velpatasvir combination for the treatment of chronic hepatitis C in patients with end stage renal disease on renal replacement therapy: A systematic review and meta‐analysis

Home‐based intensive nutrition therapy improves frailty and sarcopenia in patients with decompensated cirrhosis: A randomized clinical trial

Efficacy and safety of pan‐genotypic sofosbuvir and velpatasvir in patients with hepatitis C and HIV coinfection on dolutegravir‐based antiretroviral therapy

Combined PEG3350 Plus Lactulose Results in Early Resolution of Hepatic Encephalopathy and Improved 28-Day Survival in Acute-on-Chronic Liver Failure

Toward a Better Definition of Acute-on-Chronic Liver Failure

Aktive Filter

Suchergebnisse filtern